Osmosis has proposed merging its chain into the Cosmos Hub to make its DEX native infrastructure for the Hub. The merger would swap OSMO tokens for ATOM at a rateOsmosis has proposed merging its chain into the Cosmos Hub to make its DEX native infrastructure for the Hub. The merger would swap OSMO tokens for ATOM at a rate

Osmosis Proposal Aims to Align Cosmos Around ATOM as Core Coordination Asset

For feedback or concerns regarding this content, please contact us at [email protected]
  • Osmosis has proposed merging its chain into the Cosmos Hub to make its DEX native infrastructure for the Hub.
  • The merger would swap OSMO tokens for ATOM at a rate of 0.0355:1.998, based on price patterns in the past 30 days.

Osmosis, the largest decentralized application in the Cosmos ecosystem, has introduced a proposal to merge its DEX into the Cosmos Hub and make ATOM the main crypto asset capturing the value of all its trading activity.

The new proposal would need to be approved by the governance teams of both chains. Osmosis says, if approved, it would unify liquidity, governance and security, all under a single chain.

Sunny Aggarwal, the Osmosis founder who published the proposal, said it’s critical that the entire Cosmos ecosystem works in unity to strengthen ATOM’s direct economic foundations, especially now when the ecosystem has been contracting. As CNF reported in January, one of the key architects of the Cosmos interoperability protocol (IBC) declared that the ecosystem “is pretty much dead,” pointing to the many projects that have folded.

This makes the new proposal vital to the network’s survival and “reflects a natural evolution for Cosmos: sovereign experimentation followed by consolidation once infrastructure has matured,” Osmosis says.

Osmosis launched in 2021 and has since grown to become the largest liquidity venue for Cosmos tokens. In Cosmos, protocols build independent blockchains separate from the main Cosmos Hub, but interconnected to the rest of the ecosystem through the Inter‑Blockchain Communication (IBC) protocol. Osmosis has its own validators, governance system and token, called OSMO. 

If the new proposal is accepted, it would cease to be an independent blockchain and redeploy all its DEX modules directly on the Cosmos Hub.

Osmosis Seeks to Save Struggling Cosmos Network

The proposal represents a change in direction for the Cosmos network. For years, it has pushed projects to launch independent blockchains, and many successful projects came from this model, including Injective, Celestial and dYdX. The drawback is that the success of these projects does not reflect on ATOM as they have their own tokens, like Injective’s $296 million INJ and Celestia’s $291 million TIA.

Another challenge has been liquidity fragmentation. While all these blockchains remain interconnected through IBC, they have varying incentives and validators.

Osmosis wants to solve both challenges with its proposal. It says:

The benefit for Cosmos and ATOM will be immediate. Osmosis says it generated $5.5 million in revenue last year, and its operating costs only hit $550,000. It pledges to use this profit as a revenue stream for ATOM holders to reinvest in other Cosmos Hub initiatives.

If the migration goes through, OSMO tokens would be converted to ATOM at a rate of 0.0355 ATOM per 1.998 OSMO, based on the 30-day price patterns.

ATOM trades at $1.81, shedding 3.5% in the past week and 24% since mid-February.

]]>
Market Opportunity
COSMOS Logo
COSMOS Price(ATOM)
$1.771
$1.771$1.771
-1.39%
USD
COSMOS (ATOM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Share
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Share
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11